E-ISSN 2231-3206 | ISSN 2320-4672
 

Original Research 


A retrospective study of risk factors of Mucormycosis in COVID-19 patients at a dedicated COVID hospital

Prema Krishnarao Joshi, Kashinath Khandu Jadhav.

Abstract
Background: In the present scenario treating Mucormycosis is proving more challenging than COVID-19.

Aim and Objectives: To describe the demographic profile, clinical presentations, and risk factors of COVID-19 associated Mucormycosis.

Materials and Methods: A retrospective cross-sectional study was conducted in 30 patients. Diagnosed cases of Mucormycosis with a history of RTPCR or Rapid antigen positive for COVID infection were included in the study. Patients with a past history of Mucormycosis infection or patients not admitted in the hospital were excluded. The study began after obtaining the Institutional Ethical Committee Approval. The statistical analysis was done to study the Percentage distribution of the risk factors.

Results: About 66.66% patients were male and 33.33% were females. The age of the patients was 52.8 ± 10.3 years. About 76.66% patients were farmers/farm workers. 90% of cases had Maxillary, 25 % Ethmoid and 5% had Sphenoid sinus involved. 23.33% were known diabetic. About 63.33% were having uncontrolled blood glucose level. About 23.33% were known hypertensive. About 66.66% had received steroids, 56.66% required oxygen therapy. 36.66% required Intensive care unit (ICU) and 6.66% required ventilator support during their management of acute COVID infection. None were fully vaccinated for COVID-19.

Conclusion: The males are more susceptible to post-COVID 19 Mucormycosis infection as compared to females. Farmers/farm workers are at an increased risk too. Over use of steroids, uncontrolled blood sugar levels, oxygen therapy, long hospital stay, and ICU procedures and ventilators also contribute to the increased occurrence of post-COVID Mucormycosis. Most important factor that was observed was all the patients suffering from post-COVID Mucormycosis were not vaccinated.

Key words: COVID-19; Risk Factors; Mucormycosis; Retrospective Study


 
ARTICLE TOOLS
Abstract
PDF Fulltext
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by Prema Krishnarao Joshi
Articles by Kashinath Khandu Jadhav
on Google
on Google Scholar


How to Cite this Article
Pubmed Style

Joshi PK, Jadhav KK. A retrospective study of risk factors of Mucormycosis in COVID-19 patients at a dedicated COVID hospital. Natl J Physiol Pharm Pharmacol. 2022; 12(9): 1393-1398. doi:10.5455/njppp.2022.12.01030202217012022


Web Style

Joshi PK, Jadhav KK. A retrospective study of risk factors of Mucormycosis in COVID-19 patients at a dedicated COVID hospital. https://www.njppp.com/?mno=3998 [Access: November 24, 2022]. doi:10.5455/njppp.2022.12.01030202217012022


AMA (American Medical Association) Style

Joshi PK, Jadhav KK. A retrospective study of risk factors of Mucormycosis in COVID-19 patients at a dedicated COVID hospital. Natl J Physiol Pharm Pharmacol. 2022; 12(9): 1393-1398. doi:10.5455/njppp.2022.12.01030202217012022



Vancouver/ICMJE Style

Joshi PK, Jadhav KK. A retrospective study of risk factors of Mucormycosis in COVID-19 patients at a dedicated COVID hospital. Natl J Physiol Pharm Pharmacol. (2022), [cited November 24, 2022]; 12(9): 1393-1398. doi:10.5455/njppp.2022.12.01030202217012022



Harvard Style

Joshi, P. K. & Jadhav, . K. K. (2022) A retrospective study of risk factors of Mucormycosis in COVID-19 patients at a dedicated COVID hospital. Natl J Physiol Pharm Pharmacol, 12 (9), 1393-1398. doi:10.5455/njppp.2022.12.01030202217012022



Turabian Style

Joshi, Prema Krishnarao, and Kashinath Khandu Jadhav. 2022. A retrospective study of risk factors of Mucormycosis in COVID-19 patients at a dedicated COVID hospital. National Journal of Physiology, Pharmacy and Pharmacology, 12 (9), 1393-1398. doi:10.5455/njppp.2022.12.01030202217012022



Chicago Style

Joshi, Prema Krishnarao, and Kashinath Khandu Jadhav. "A retrospective study of risk factors of Mucormycosis in COVID-19 patients at a dedicated COVID hospital." National Journal of Physiology, Pharmacy and Pharmacology 12 (2022), 1393-1398. doi:10.5455/njppp.2022.12.01030202217012022



MLA (The Modern Language Association) Style

Joshi, Prema Krishnarao, and Kashinath Khandu Jadhav. "A retrospective study of risk factors of Mucormycosis in COVID-19 patients at a dedicated COVID hospital." National Journal of Physiology, Pharmacy and Pharmacology 12.9 (2022), 1393-1398. Print. doi:10.5455/njppp.2022.12.01030202217012022



APA (American Psychological Association) Style

Joshi, P. K. & Jadhav, . K. K. (2022) A retrospective study of risk factors of Mucormycosis in COVID-19 patients at a dedicated COVID hospital. National Journal of Physiology, Pharmacy and Pharmacology, 12 (9), 1393-1398. doi:10.5455/njppp.2022.12.01030202217012022